John A. Herrmann was Promoted to General Counsel at Novavax

Date of management change: March 08, 2012 

What Happened?

Gaithersburg, MD-based Novavax has Promoted John A. Herrmann as General Counsel

 

About the Company

Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company, employs its cutting-edge technology to create next-generation vaccines to prevent serious infectious diseases, such as pandemic and seasonal influenza and respiratory syncytial virus (RSV). The company’s proprietary virus-like-particle (VLP) technology and single-use bioprocessing system enable rapid vaccine development and production where and when they are needed, worldwide. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company’s website

 

About the Person

John A. Herrmann is Executive Vice President and Chief Legal Officer at Novavax. Previously, John held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Harrington Michael, Balachandran Rob, Miller Nicole, DiGiovanni Shauna, Mcafee Scott, Spencer Jonathan, Revaz Cris, Choroszucha Lech, Palecki Scott, Motlagh Angele, Kulkarni Sachin

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.